Clinical trial Recruiting at 1 site Interventional Ages 18 to 35

BIG payment for young people with HIV

Official title: BIG Chicago: A Trial of Basic Income Guarantee for Young People Living With HIV

Run by University of Chicago · NCT07502365 · Data updated 2026-11-12

This study tests whether giving a basic income to young adults living with HIV helps them stay in care and achieve viral suppression better than usual care alone.

Quick facts

Study typeInterventional
Ages18 Years to 35 Years
SexAll
Enrollment304 (estimated)
SponsorUniversity of Chicago
Academic / other
Locations1 site (Chicago, Illinois)
StatusRecruiting
StartedJuly 29, 2026
Main results expectedJuly 2030
Study endsJuly 2030
Registry record updatedAugust 6, 2026
Trial IDNCT07502365 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 18-35 living with HIV, with recent gaps in care or unsuppressed viral load, who have financial distress and income at or below 250% of the federal poverty level, and who are English-speaking.

Probably not a fit

Participants without a financial need or those who do not experience barriers to care may see little or no additional benefit from the basic income intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized trial will compare Basic Income Guarantee plus standard HIV care versus standard care alone in adults aged 18-35 with HIV who have experienced financial hardship. Participants will be randomly assigned to one of the two groups and followed for 36 months, with up to 9 surveys and access to electronic medical record data for 54 months in total. The primary aim is to see if BIG improves engagement in care and viral suppression compared with treatment as usual. Eligibility includes living with HIV for at least two years, recent care gaps or unsuppressed viral load, income under 250% of the federal poverty level, and financial distress. The lead site is the University of Chicago, with NIMH collaboration, enrolling 304 participants recruited through community networks and HIV care providers.

Why it matters

Potential benefit: If successful, participants may experience improved engagement in care and better viral suppression, potentially reducing health risks and improving quality of life.

How similar studies have gone: Prior work suggests financial supports can influence health behaviors, but this exact Basic Income Guarantee approach for HIV care engagement is relatively novel and its effectiveness is being tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Living with HIV for 24 months or longer;
* Ages 18-35;
* English-speaking;
* One or both of the following:

  1. Experienced a gap in HIV provider care of 6 or greater months during the prior 12-month period;
  2. Had an unsuppressed viral load at any point within the prior 12-month period (unsuppressed meaning a viral load of 200 copies/mL or higher);
* Household income at or below 250% of the Federal Poverty Level; and
* Experiencing financial distress, as based on a financial well-being score of 1-4 (high financial distress).

Exclusion Criteria:

* Unwilling/unable to provide informed consent
* Unable to confirm HIV status
* Unable to conduct the study in English

Where it's running

  • University of Chicago
    Chicago, Illinois, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.